Cover Image
市場調查報告書

越南的醫藥品、醫療產業(季度更新報告)

Vietnam Pharmaceuticals and Healthcare Report Q4 2016

出版商 BMI Research 商品編碼 179567
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
越南的醫藥品、醫療產業(季度更新報告) Vietnam Pharmaceuticals and Healthcare Report Q4 2016
出版日期: 2016年10月26日 內容資訊: 英文 112 Pages
簡介

本報告提供越南的製藥、醫療產業結構和最新趨勢相關分析,今後10年的產業規模的動向估計,產業的課題(風險)和未來商機(利潤)相關評估,政府的政策、規定,宏觀經濟環境,主要企業簡介等資訊彙整,為您概述為以下內容。

BMI的見解

SWOT分析

產業預測

  • 醫藥品市場預測
  • 醫療市場預測
  • 處方藥市場預測
  • 專利藥市場預測
  • 學名藥市場預測
  • 一般用(OTC)醫藥品市場預測
  • 醫藥品的對外貿易情形

產業的風險/利潤、等級

  • 亞太地區:風險/利潤、等級
  • 越南:風險/利潤、等級
    • 利潤
    • 風險

相關法規

  • 知識產權的問題
  • 價格設定的體制
    • 醫療費償付的體制

市場概況

  • 醫療部門的資金籌措
  • 研究開發(R&D)
  • 臨床實驗

競爭環境

  • 研究開發意向型產業
  • 醫藥品的流通
  • 醫藥品的零售部門

企業簡介

人口動態預測

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤、等級技術
  • 等級概要
  • 指標的加權

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1748-2305

BMI View: Ongoing regulatory reform and the relaxation of the 49% cap on foreign ownership will continue to increase the appeal of Vietnamese pharmaceutical equities to foreign investors. This trend will reflect the government efforts to attract foreign investment in order to develop the pharmaceutical sector as well as foreign companies aim to gain a competitive edge in the domestic market. However, due to public procurement bias towards local producers, the rise of domestic pharmaceutical companies will also present competitive threats to multinational drugmakers operating in the country, eventually leading to variations in their business models.

Headline Expenditure Projections

  • Pharmaceuticals: VND92.5trn (USD4.2bn) in 2015 to VND105.6trn (USD4.7bn) in 2016; +14.2% in local currency terms and +11.7% in US dollar terms. Forecast in line in local currency terms and revised slightly upwards in US dollar terms compared to the last quarter.
  • Healthcare: VND304.5trn (USD13.9bn) in 2015 to VND333.6bn (USD14.9bn) in 2016; +9.6% in local currency terms and +7.2% in US dollar terms. Forecast revised slightly upwards compared to the last quarter.

Table of Contents

BMI Industry View

  • Table: Headline Pharmaceuticals & Healthcare Forecasts (Vietnam 2014-2020)

SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
    • Table: Pharmaceutical Sales, Historical Data And Forecasts (Vietnam 2012-2020)
  • Healthcare Market Forecast
    • Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020)
    • Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020)
    • Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020)
  • Prescription Drug Market Forecast
    • Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020)
  • Patented Drug Market Forecast
    • Table: Patented Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020)
  • Generic Drug Market Forecast
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020)
  • OTC Medicine Market Forecast
    • Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020)
  • Pharmaceutical Trade Forecast
    • Table: Pharmaceutical Trade Data And Forecasts (Vietnam 2014-2020)
    • Table: Pharmaceutical Trade Data And Forecasts local currency (Vietnam 2014-2020)

Pharmaceuticals & Healthcare Risk/Reward Index

  • Asia Pacific Risk/Reward Index - Q4 2016
  • Vietnam Risk/Reward Index
    • Rewards
    • Risks

Regulatory Review

  • Intellectual Property Issues
    • Table: Special 301 Submission: Issues Raised For Vietnam
  • Pricing Regime
    • Reimbursement Regime

Market Overview

  • Healthcare Sector
    • Table: Healthcare Resources (Vietnam 2010-2015)
    • Table: Healthcare Personnel (Vietnam 2010-2015)
    • Table: Healthcare Activity (Vietnam 2010-2015)
  • Research & Development

Competitive Landscape

  • Research-Based Industry
    • Table: Multinational Market Activity
  • Pharmaceutical Distribution
  • Pharmaceutical Retail Sector
    • Table: Key Aspects Of Good Pharmacy Practice In Developing Countries

Company Profile

  • DHG Pharmaceutical
  • GlaxoSmithKline
  • Sanofi
  • Traphaco Pharmaceutical
  • Vietnam Pharmaceutical Corporation (Vinapharm)

Demographic Forecast

  • Table: Population Headline Indicators (Vietnam 1990-2025)
  • Table: Key Population Ratios (Vietnam 1990-2025)
  • Table: Urban/Rural Population & Life Expectancy (Vietnam 1990-2025)
  • Table: Population By Age Group (Vietnam 1990-2025)
  • Table: Population By Age Group % (Vietnam 1990-2025)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
  • Index Overview
    • Table: Pharmaceutical Risk/Reward Index Indicators
  • Indicator Weightings
Back to Top